Psychogenic Seizure: 5 Strategies to Assess and Treat
Is it a seizure or something else? Here are 5 tips to assess and treat psychogenic non-epileptic seizures.
What’s in a Name? The Seizure Classification Update and What It All Means
The conventional classification of seizure types needed a makeover. To employ the 2017 ILAE classification, a clinician should follow some general rules.
The Neglected Diagnosis: Mood Disorders in Patients With Epilepsy
Which came first? Epilepsy or depression? The author sheds light on a complex relationship.
Maternal Obesity and Epilepsy
New findings may have an impact on reducing the epilepsy disease burden in future generations.
Anticonvulsant Potiga Discontinued in June 2017
The anticonvulsant known as Potiga (ezogabine) in the US and as Trobalt (retigabine) in Europe will be discontinued by the manufacturer at the end of June. Details here.
New Insights About Accelerated Long-Term Forgetting in Epilepsy
Here’s evidence that ALF may be an important memory disorder in subgroups of patients with epilepsy.
How Common Is Sudden Unexpected Death in Epilepsy?
Here is new evidence that the incidence of SUDEP is higher than expected in boys, people with psychiatric comorbidities, and other groups. Details here.
Pregnancy Outcomes with Pregabalin Use
In this Medical News Minute, Dr. Bobby Lazzara highlights possible birth defects resulting from women taking pregabalin during pregnancy.
Modeling Simulations to Predict AED Efficacy
Researchers used simulations to predict the outcomes of epilepsy patients with partial-onset seizures converting to Aptiom monotherapy (800 mg QD).
Potential Treatment for SRSE
Research leading up to the ongoing phase 3 trial of SAGE-547, a potential drug for super-refractory status epilepticus, was presented at AAN 2016.
Antiepileptic Drug Choice: Patient vs Neurologist
Do you and your patients with epilepsy agree on treatment decisions? A national survey compares AED attribute preferences of patients and neurologists.
Interesting Neuro: Stroke Warning & Cluster Headache
May news includes ground-breaking FDA approvals, predictions of Alzheimer disease, and a possible biomarker for mild traumatic brain injury.
Interesting Neuro: New Drugs & TBI Recovery
April news includes tools to manage brain injury and predict recovery, new drug hits and misses, and an updated epilepsy classification system.
By clicking Accept, you agree to become a member of the UBM Medica Community.